Inhibiting CD164 Expression in Colon Cancer Cell Line HCT116 Leads to Reduced Cancer Cell Proliferation, Mobility, and Metastasis in vitro and in vivo
Publication in refereed journal


Times Cited
Web of Science24WOS source URL (as at 16/10/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBackground: CD164 (Endolyn) is a sialomucin, which has been found to play roles in regulating proliferation, adhesion, and differentiation of hematopoietic stem cells. Possible association of CD164 with solid cancer development remains unknown.
All Author(s) ListTang JQ, Zhang LY, She XL, Zhou GQ, Yu FL, Xiang JJ, Li G
Journal nameCancer Investigation
Detailed descriptionTo ORKTS: doi: 10.3109/07357907.2012.666692
(duplicated record)
Year2012
Month6
Day1
Volume Number30
Issue Number5
PublisherINFORMA HEALTHCARE
Pages380 - 389
ISSN0735-7907
LanguagesEnglish-United Kingdom
KeywordsCD164; Colon cancer; CXCR4; Metastasis
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-17-10 at 00:48